Literature DB >> 8756725

The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

T Wang1, B Y Li, P D Danielson, P C Shah, S Rockwell, R J Lechleider, J Martin, T Manganaro, P K Donahoe.   

Abstract

The immunophilin FKBP12 is an evolutionarily conserved abundant protein; however, its physiological roles remain poorly defined. Here we report that FKBP12 is a common cytoplasmic interactor of TGF beta family type I receptors. FKBP12 binds to ligand-free TGF beta type I receptor, from which it is released upon a ligand-induced, type II receptor mediated phosphorylation of the type I receptor. Blocking FKBP12/type I receptor interaction with FK506 nonfunctional derivatives enhances the ligand activity, indicating that FKBP12 binding is inhibitory to the signaling pathways of the TGF beta family ligands. Overexpression of a myristylated FKBP12 in Mv1Lu cell specifically inhibits two separate pathways activated by TGF beta, and two point mutations on FKBP12 (G89P, I90K) abolish the inhibitory activity of FKBP12, suggesting that FKBP12 may dock a cytoplasmic protein to the type I receptors to inhibit TGF beta family mediated signaling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8756725     DOI: 10.1016/s0092-8674(00)80116-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  95 in total

1.  Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Mérino ewes.

Authors:  P Mulsant; F Lecerf; S Fabre; L Schibler; P Monget; I Lanneluc; C Pisselet; J Riquet; D Monniaux; I Callebaut; E Cribiu; J Thimonier; J Teyssier; L Bodin; Y Cognié; N Chitour; J M Elsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension.

Authors:  Valorie L Chiasson; Deepa Talreja; Kristina J Young; Piyali Chatterjee; Amy K Banes-Berceli; Brett M Mitchell
Journal:  Hypertension       Date:  2011-04-25       Impact factor: 10.190

3.  Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level?

Authors:  G Canaud; B Knebelmann; P C Harris; F Vrtovsnik; J-M Correas; N Pallet; C M Heyer; E Letavernier; F Bienaimé; E Thervet; F Martinez; F Terzi; C Legendre
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

4.  FK506 microparticles mitigate experimental colitis with minor renal calcineurin suppression.

Authors:  Alf Lamprecht; Hiromitsu Yamamoto; Nathalie Ubrich; Hirofumi Takeuchi; Philippe Maincent; Yoshiaki Kawashima
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

5.  FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.

Authors:  C M Alarcón; J Heitman
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 6.  Calcium at fertilization and in early development.

Authors:  Michael Whitaker
Journal:  Physiol Rev       Date:  2006-01       Impact factor: 37.312

7.  The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes.

Authors:  Silvia Colucci; Alessia Pagani; Mariateresa Pettinato; Irene Artuso; Antonella Nai; Clara Camaschella; Laura Silvestri
Journal:  Blood       Date:  2017-09-01       Impact factor: 22.113

8.  TGF beta 1 inhibits Ca2+-calcineurin-mediated activation in thymocytes.

Authors:  Ramireddy Bommireddy; Ilona Ormsby; Moying Yin; Gregory P Boivin; George F Babcock; Thomas Doetschman
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Interaction of calmodulin, a sorting nexin and kinase-associated protein phosphatase with the Brassica oleracea S locus receptor kinase.

Authors:  Vincent Vanoosthuyse; Gabrielle Tichtinsky; Christian Dumas; Thierry Gaude; J Mark Cock
Journal:  Plant Physiol       Date:  2003-10       Impact factor: 8.340

10.  BMP10 is essential for maintaining cardiac growth during murine cardiogenesis.

Authors:  Hanying Chen; Shu Shi; Lourdes Acosta; Weiming Li; Jonathan Lu; Shideng Bao; Zhuang Chen; Zuocheng Yang; Michael D Schneider; Kenneth R Chien; Simon J Conway; Mervin C Yoder; Laura S Haneline; Diego Franco; Weinian Shou
Journal:  Development       Date:  2004-04-08       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.